Legislative Observatory
European Parliament
Please fill in this field to find a procedure

2005 discharge: European Monitoring Centre for Drugs and Drug Addiction

2006/2157(DEC)

PURPOSE: presentation of the final accounts of the European Monitoring Centre for Drugs and Drug Addiction for the financial year 2005.

CONTENT: this document published in the Official Journal of the EU sets out a detailed account of the implementation of the 2005 budget, including the revenue and expenditure and the balance sheet for the year concerned.

According to this document, the final budget amounted to EUR 12.8 million (compared to EUR 12.2 million in 2004) including a 96% Community subsidy.

As regards the staffing policy, the Monitoring Centre, whose headquarters is based in Lisbon (Portugal), officially set out 77 posts in its establishment plan. 58 posts are currently occupied + 25 other staff (auxiliary contracts, contract staff and temporary replacements) totalling 83 staff assigned to operational, administrative and IT support tasks and mixed duties. Staff expenditure amounted to EUR 6.2 million in 2005.

Its main task is to collect data on drugs and drug addiction in order to prepare and publish information that is objective, reliable and comparable at European level. The information is intended to provide a basis for analysing demand for drugs and ways of reducing both it and drug-market-related events in general. The Centre runs a computerised network for the collection and exchange of information called the ‘European Information Network on Drugs and Drug Addiction’ (Reitox); this network connects national drug information networks, specialist centres in the Member States and the information systems of international organisations working with the Centre.

In 2005, the Centre published:

  • Annual report on the state of the drug problem in Europe (22 language versions, publication and interactive website);
  • Annual report on selected issues (EN, publication and interactive website);
  • Statistical bulletin and interactive website containing over 200 tables, 100 graphs and PDF files;
  • General activity report (annual, EN);
  • Drugnet Europe newsletter (4 issues, two of them in five languages and two in EN, 12 products);
  • Technical and scientific studies and articles (28).

Other websites: Set-up/updating/content development:

  • Country situation summaries;
  • Country data profiles;
  • Drug treatment overviews;
  • European legal database on drugs;
  • Evaluation instruments bank;
  • Exchange on drug demand reduction action.

Promotional brochures: 3 products.

Media products: 110 miscellaneous products.

Participation in international conferences/meetings:75.

Organisation of technical and scientific meetings: 24.

The complete version of the final accounts may be found at the following address:

http://www.emcdda.europa.eu/index.cfm?fuseaction=public.Content&nNodeID=6465&sLanguageISO=EN